Investor profile
Samsung Venture Investment Corporation (SVIC)
CVC
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Samsung Ventures is a technology-driven corporate venture capital firm committed to driving growth and creating new value through technological innovation. Since its founding in 1999, the firm has leveraged its experience and expertise to actively invest in companies developing breakthrough technologies with the potential to transform industries. Through its global networks and industry insights, Samsung Ventures partners with portfolio companies to drive sustainable growth together. The firm is stage-agnostic — investing anywhere from early stage to pre-IPO — and focuses on AI, robotics, device solutions, bio & health, energy, security & privacy, IT & enterprise, and consumer & devices, backing startups with global impact that can benefit from and contribute to Samsung's massive platform.
Notable quotes
“SVIC is stage-agnostic, investing anywhere from early stage to pre-IPO, focusing on areas like artificial intelligence and machine learning, semiconductors, telecommunication, software, internet technology, digital health, fintech, insurtech, biotechnology, energy storage, display, climate, sustainability and more.”
“We're more thesis-driven investors because we are technology investors first. Being thesis-driven allows us to think about how the technology may fit within Samsung's massive platform and how our platform can be the fuel to the potential portfolio companies' fire.”
Team
Albert Kim
Executive Vice President & Head of Americas
Calix Sohn
Head of Investment Division
Chanwoo Yang
Director of Investments
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Anthropic | Series H | $65.0b | 2026-05 |
| d-Matrix | Series B | $110m | 2023-09 |
| Mistral AI | Series B | — | 2024 |
| Rebellions | Series B | — | 2023 |
| Figure AI | Series B | $675m | 2024 |
| World Labs | Series A | — | 2024 |
| Carbon Clean | Series C | — | 2023 |
| Elion Therapeutics | Series B | $81m | 2024-06 |
| SentinelOne | Series E (pre-IPO) | — | — |
| Subtle Medical | Series C | — | 2026-06 |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Temasek | 3 |
| Qualcomm Ventures | 3 |
| SoftBank Ventures Asia | 3 |
| Intel Capital | 2 |
| Khosla Ventures | 2 |
| M12 (Microsoft Venture Fund) | 2 |
Fit check
Is Samsung Venture Investment Corporation (SVIC) a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit